MedPath

ingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial

Phase 1
Recruiting
Conditions
novel coronavirus pneumonia (COVID-19)
Quality of life and mental health status
Registration Number
ITMCTR2000003245
Lead Sponsor
The First Afflicated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. in line with epidemiological history survey and negative forCOVID-19 RNA screening
2. in line with inclusion criteria and voluntarily receive fire needle treatment
3. Aged 18 to 65 years old;
4. Quality of life score<=37;
5. Voluntary participation in this study and sign informed consent.

Exclusion Criteria

1. People who are taking anticoagulant drugs (such as warfarin), or have received other related treatments, may affect the indicators of this study;
2. Pregnant women;
3. Those who cannot tolerate fire needles due to allergies, stress, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life score;
Secondary Outcome Measures
NameTimeMethod
Mental health score;
© Copyright 2025. All Rights Reserved by MedPath